Clinical Study

The Safety and Efficacy of Routine Administration of Intracameral Vancomycin during Cataract Surgery

Table 1

The means and distributions with standard deviations of the baseline characteristics among the group that received and the group that did not receive intracameral vancomycin during cataract surgery.

Baseline characteristicDid not receive intracameral vancomycin
()
Did receive intracameral vancomycin
()
value

Age (years)71.3 (8.5)70.6 (9.0)
GenderMale = 5,610 (49.5%)
Female = 5,723 (50.5%)
Male = 4,623 (49.3%)
Female = 4,763 (50.7%)
Laterality Right eye = 5,689 (50.2%)
Left eye = 5,644 (49.8%)
Right eye = 4,698 (50.1%)
Left eye = 4,688 (49.9%)
Preoperative BSCVA (logMAR) 0.51 (0.26)0.49 (0.31)
Axial length (mm)23.9 (1.5)24.1 (1.4)
Average keratometry (diopters)43.2 (2.2)43.3 (2.3)
Underlying ocular Comorbidities Yes = 1,190 (10.5%)
No = 10,143 (89.5%)
Yes = 975 (10.4%)
No = 8,411 (89.6%)
Previous history of ocular surgery Yes = 1,473 (13.0%)
No = 9,860 (87.0%)
Yes = 1,239 (13.2%)
No = 8,147 (86.8%)